Citação norma APA

Horita, N., Goto, A., Shibata, Y., Ota, E., Nakashima, K., Nagai, K., & Kaneko, T. (2017). Long‐acting muscarinic antagonist (LAMA) plus long‐acting beta‐agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease (COPD). Cochrane Database Syst Rev.

Citação norma Chicago

Horita, Nobuyuki, Atsushi Goto, Yuji Shibata, Erika Ota, Kentaro Nakashima, Kenjiro Nagai, and Takeshi Kaneko. "Long‐acting Muscarinic Antagonist (LAMA) Plus Long‐acting Beta‐agonist (LABA) Versus LABA Plus Inhaled Corticosteroid (ICS) for Stable Chronic Obstructive Pulmonary Disease (COPD)." Cochrane Database Syst Rev 2017.

Citação norma MLA

Horita, Nobuyuki, et al. "Long‐acting Muscarinic Antagonist (LAMA) Plus Long‐acting Beta‐agonist (LABA) Versus LABA Plus Inhaled Corticosteroid (ICS) for Stable Chronic Obstructive Pulmonary Disease (COPD)." Cochrane Database Syst Rev 2017.

Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.